company background image
KDSK.F logo

DSM-Firmenich OTCPK:KDSK.F Stock Report

Last Price

US$25.30

Market Cap

US$34.0b

7D

0%

1Y

-15.7%

Updated

20 Oct, 2024

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

KDSK.F Stock Overview

Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. More details

KDSK.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance0/6
Financial Health5/6
Dividends1/6

My Notes

Capture your thoughts, links and company narrative

DSM-Firmenich AG Competitors

Price History & Performance

Summary of share price highs, lows and changes for DSM-Firmenich
Historical stock prices
Current Share Price€25.30
52 Week High€120.00
52 Week Low€12.50
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Change-15.67%
3 Year Change-88.37%
5 Year Change-78.74%
Change since IPO-44.85%

Recent News & Updates

Recent updates

Shareholder Returns

KDSK.FUS ChemicalsUS Market
7D0%-3.0%0.1%
1Y-15.7%-0.09%26.1%

Return vs Industry: KDSK.F underperformed the US Chemicals industry which returned 24.5% over the past year.

Return vs Market: KDSK.F underperformed the US Market which returned 38.4% over the past year.

Price Volatility

Is KDSK.F's price volatile compared to industry and market?
KDSK.F volatility
KDSK.F Average Weekly Movementn/a
Chemicals Industry Average Movement5.4%
Market Average Movement6.3%
10% most volatile stocks in US Market16.7%
10% least volatile stocks in US Market3.1%

Stable Share Price: KDSK.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine KDSK.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
190227,926Dimitri de Vreezewww.dsm-firmenich.com

DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.

DSM-Firmenich AG Fundamentals Summary

How do DSM-Firmenich's earnings and revenue compare to its market cap?
KDSK.F fundamental statistics
Market capUS$34.04b
Earnings (TTM)-US$206.41m
Revenue (TTM)US$13.53b

2.5x

P/S Ratio

-164.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KDSK.F income statement (TTM)
Revenue€12.46b
Cost of Revenue€9.07b
Gross Profit€3.39b
Other Expenses€3.58b
Earnings-€190.00m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Feb 13, 2025

Earnings per share (EPS)-0.72
Gross Margin27.19%
Net Profit Margin-1.53%
Debt/Equity Ratio20.6%

How did KDSK.F perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

-130%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/20 09:22
End of Day Share Price 2024/08/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DSM-Firmenich AG is covered by 61 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mutlu GundoganABN AMRO Bank N.V.
Martin SchneeAlphaValue
Volker BosseBaader Helvea Equity Research